Health Outcomes Strategies
Health Outcomes Strategies
  • About us
    • The HOS Team
    • Our Clients
    • Contact us
  • Our work
    • Who – What for
    • Network
    • How
    • Services
      • Overview
      • Case studies
      • Edu-2-Go
    • Training
  • Conferences
  • Publications
    • Impact, value or economic analyses for diagnostics
    • Impact, value or economic analyses for pharmaceuticals
    • Impact, value or economic analyses for medical devices
    • Impact, value or economic analyses in low to medium income countries
    • Strategy development for pharmaceutical companies
    • Personalized medicine
    • European healthcare systems
    • Disease management
    • Drug shortages
    • Health data management and health information technology
    • Medical and biological research
  • Edu-Clips
  • Philanthropy
  • Need a Break?

Difficult to agree on what is Value …..

Anke Regulations, Reimbursement, Value

There is a lot of talk in industry, among the public, or among payers about VALUE related to health services or products. But do they mean the same, when they talk about it. Read a recent (March 2015) assay by Ed Schoonveld in ‘PharmExec.com’ : http://www.pharmexec.com/can-payers-and-drug-industry-agree-real-value?

Copyright © 2021 Health Outcomes Strategies

Design by Webvision Communication GmbH